ARFGEF3 and breast cancer: We found that endogenous BIG3 interacts with PKA in breast cancer cells (Fig. 1c, Supplementary Fig. 1i) and that depletion of PKA led to almost complete suppression of the E2-induced serine and threonine phosphorylation levels of BIG3 (Fig. 1d).